These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

793 related articles for article (PubMed ID: 25540987)

  • 1. A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set.
    Chiarotto A; Terwee CB; Deyo RA; Boers M; Lin CW; Buchbinder R; Corbin TP; Costa LO; Foster NE; Grotle M; Koes BW; Kovacs FM; Maher CG; Pearson AM; Peul WC; Schoene ML; Turk DC; van Tulder MW; Ostelo RW
    Trials; 2014 Dec; 15():511. PubMed ID: 25540987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Core outcome domains for clinical trials in non-specific low back pain.
    Chiarotto A; Deyo RA; Terwee CB; Boers M; Buchbinder R; Corbin TP; Costa LO; Foster NE; Grotle M; Koes BW; Kovacs FM; Lin CW; Maher CG; Pearson AM; Peul WC; Schoene ML; Turk DC; van Tulder MW; Ostelo RW
    Eur Spine J; 2015 Jun; 24(6):1127-42. PubMed ID: 25841358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Core Outcome Measures in Effectiveness Trials (COMET) initiative: protocol for an international Delphi study to achieve consensus on how to select outcome measurement instruments for outcomes included in a 'core outcome set'.
    Prinsen CA; Vohra S; Rose MR; King-Jones S; Ishaque S; Bhaloo Z; Adams D; Terwee CB
    Trials; 2014 Jun; 15():247. PubMed ID: 24962012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creation of a core outcome set for clinical trials of people with shoulder pain: a study protocol.
    Gagnier JJ; Page MJ; Huang H; Verhagen AP; Buchbinder R
    Trials; 2017 Jul; 18(1):336. PubMed ID: 28728574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a core outcome set for clinical trials in squamous cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
    Schlessinger DI; Iyengar S; Yanes AF; Chiren SG; Godinez-Puig V; Chen BR; Kurta AO; Schmitt J; Deckert S; Furlan KC; Poon E; Cartee TV; Maher IA; Alam M; Sobanko JF
    Trials; 2017 Jul; 18(1):321. PubMed ID: 28701207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A core outcome set for all types of cardiac surgery effectiveness trials: a study protocol for an international eDelphi survey to achieve consensus on what to measure and the subsequent selection of measurement instruments.
    Moza A; Benstoem C; Autschbach R; Stoppe C; Goetzenich A
    Trials; 2015 Dec; 16():545. PubMed ID: 26625730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol for the development of a core outcome set for pelvic girdle pain, including methods for measuring the outcomes: the PGP-COS study.
    Wuytack F; Gutke A; Stuge B; Mørkved S; Olsson C; Robinson HS; Vøllestad NK; Öberg B; Wikmar LN; Mena JJS; Smith V
    BMC Med Res Methodol; 2018 Dec; 18(1):158. PubMed ID: 30509216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes for Pressure Ulcer Trials (OUTPUTs): protocol for the development of a core domain set for trials evaluating the clinical efficacy or effectiveness of pressure ulcer prevention interventions.
    Lechner A; Kottner J; Coleman S; Muir D; Bagley H; Beeckman D; Chaboyer W; Cuddigan J; Moore Z; Rutherford C; Schmitt J; Nixon J; Balzer K
    Trials; 2019 Jul; 20(1):449. PubMed ID: 31331366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Core Outcome Set for GROwth restriction: deVeloping Endpoints (COSGROVE).
    Healy P; Gordijn S; Ganzevoort W; Beune I; Baschat A; Khalil A; Kenny L; Bloomfield F; Daly M; Papageorghiou A; Devane D
    Trials; 2018 Aug; 19(1):451. PubMed ID: 30134949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A core outcome set for clinical trials in whiplash-associated disorders (WAD): a study protocol.
    Maujean A; Carroll L; Curatolo M; Elliott J; Kasch H; Walton D; Sterling M
    Trials; 2018 Nov; 19(1):635. PubMed ID: 30454057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a core outcome set for clinical trials in basal cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
    Schlessinger DI; Iyengar S; Yanes AF; Lazaroff JM; Godinez-Puig V; Chen BR; Kurta AO; Henley JK; Chiren SG; Furlan KC; Schmitt J; Deckert S; Poon E; Sobanko JF; Cartee TV; Alam M; Maher IA
    Trials; 2017 Oct; 18(1):490. PubMed ID: 29061190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a core outcome set (COS) and selecting outcome measurement instruments (OMIs) for non-valvular atrial fibrillation in traditional Chinese medicine clinical trials: study protocol.
    Qiu R; Li M; Zhang X; Chen S; Li C; Shang H
    Trials; 2018 Oct; 19(1):541. PubMed ID: 30290840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes in Trials for Management of Caries Lesions (OuTMaC): protocol.
    Schwendicke F; Lamont T; Innes N
    Trials; 2015 Sep; 16():397. PubMed ID: 26346538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Core Outcome Set for Studies on Obesity in Pregnant Patients (COSSOPP): a study protocol.
    Dadouch R; Faheim M; Juando-Prats C; Parsons J; D'Souza R;
    Trials; 2018 Nov; 19(1):655. PubMed ID: 30482249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol.
    Kelly A; Tong A; Tymms K; March L; Craig JC; De Vera M; Evans V; Hassett G; Toupin-April K; van den Bemt B; Teixeira-Pinto A; Alten R; Bartlett SJ; Campbell W; Dawson T; Gill M; Hebing R; Meara A; Nieuwlaat R; Shaw Y; Singh JA; Suarez-Almazor M; Sumpton D; Wong P; Christensen R; Beaton D; de Wit M; Tugwell P;
    Trials; 2018 Mar; 19(1):204. PubMed ID: 29587864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 'Outcome Reporting in Brief Intervention Trials: Alcohol' (ORBITAL) framework: protocol to determine a core outcome set for efficacy and effectiveness trials of alcohol screening and brief intervention.
    Shorter GW; Heather N; Bray JW; Giles EL; Holloway A; Barbosa C; Berman AH; O'Donnell AJ; Clarke M; Stockdale KJ; Newbury-Birch D
    Trials; 2017 Dec; 18(1):611. PubMed ID: 29273070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IMMPACT-recommended outcome measures and tools of assessment in burning mouth syndrome RCTs: an international Delphi survey protocol.
    Carey B; Farag AM; Nasri-Heir C; Klasser GD; Ariyawardana A; Chmieliauskaite M; Sardella A; Carlson CR; Miller CS; Mejia L; O'Neill FE; Albuquerque R
    Trials; 2020 Aug; 21(1):711. PubMed ID: 32787910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical Handover Core Outcome Measures (SH-CORE): a protocol for the development of a core outcome set for trials in surgical handover.
    Ryan JM; Devane D; Simiceva A; Eppich W; Kavanagh DO; Cullen C; Hogan AM; McNamara DA
    Trials; 2024 Jun; 25(1):373. PubMed ID: 38858749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome set.
    Harman NL; Wilding J; Curry D; Harris J; Logue J; Pemberton RJ; Perreault L; Thompson G; Tunis S; Williamson PR;
    Trials; 2018 Aug; 19(1):427. PubMed ID: 30086771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COS-STAR: a reporting guideline for studies developing core outcome sets (protocol).
    Kirkham JJ; Gorst S; Altman DG; Blazeby J; Clarke M; Devane D; Gargon E; Williamson PR;
    Trials; 2015 Aug; 16():373. PubMed ID: 26297658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.